4.5 (232) · € 22.50 · En Stock
For the first time, a researcher at the University of Delaware College of Health Sciences in collaboration with a team at the National Institute on Aging, a division of the National Institutes of Health, has determined that the naturally occurring dietary supplement known as nicotinamide riboside (NR) can enter the brain.
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial - The Lancet Neurology
Experts present pioneering vision on reducing brain disorders by 2050
Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing, British Journal of Nutrition
PDF) Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer's disease: a narrative review
IJMS, Free Full-Text
Frontiers Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study
Researchers link supplement to reduced biomarkers of Alzheimer's in the brain
TaubCONNECT Research Perspectives
Frontiers Nanomedicine: A Promising Way to Manage Alzheimer's Disease
MAKE, Free Full-Text